1. Home
  2. NMRK vs WVE Comparison

NMRK vs WVE Comparison

Compare NMRK & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newmark Group Inc.

NMRK

Newmark Group Inc.

N/A

Current Price

$17.22

Market Cap

3.1B

Sector

Finance

ML Signal

N/A

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$16.33

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NMRK
WVE
Founded
1929
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
1.2B
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
NMRK
WVE
Price
$17.22
$16.33
Analyst Decision
Buy
Strong Buy
Analyst Count
6
16
Target Price
$19.40
$29.44
AVG Volume (30 Days)
1.2M
13.3M
Earning Date
10-30-2025
11-10-2025
Dividend Yield
0.70%
N/A
EPS Growth
94.50
N/A
EPS
0.59
N/A
Revenue
$3,160,782,000.00
$109,230,000.00
Revenue This Year
$21.82
N/A
Revenue Next Year
$10.10
$31.09
P/E Ratio
$29.13
N/A
Revenue Growth
20.95
103.75
52 Week Low
$9.65
$5.28
52 Week High
$19.84
$21.73

Technical Indicators

Market Signals
Indicator
NMRK
WVE
Relative Strength Index (RSI) 49.51 66.45
Support Level $16.98 $15.86
Resistance Level $17.61 $17.41
Average True Range (ATR) 0.55 1.67
MACD 0.03 0.57
Stochastic Oscillator 47.00 63.72

Price Performance

Historical Comparison
NMRK
WVE

About NMRK Newmark Group Inc.

Newmark Group Inc is a commercial real estate advisory firm. It offers services, including leasing and corporate advisory services, investment sales, commercial mortgage brokerage, appraisal and valuation, project management, and property, among others. Newmark offers a diverse array of integrated services and products designed to meet the full needs of both real estate investors/owners and occupiers. The company provides real estate strategic consulting and systems integration services to CFI's clients including many Fortune and Forbes companies, owner-occupiers, government agencies, healthcare, and higher education clients.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: